BioAffinity Technologies Prices $4 Million Registered Direct Offering
MT newswire2026/10/08 16:5212:52 PM EDT, 10/08/2026 (MT Newswires) -- BioAffinity Technologies (BIAF) said Thursday it entered into a definitive agreement with an institutional investor to sell shares of common stock at $6.122 per share in a registered direct offering. In a concurrent private placement, the company will also sell warrants to purchase up to 980,072 shares at an exercise price of $6.122 per share. The offering is expected to raise gross proceeds of about $4 million, which the company intends to use for working capital, to support sales of CyPath Lung, and for general corporate purposes. The offering is expected to close on Thursday. Price: 6.10, Change: -0.06, Percent Change: -0.97
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Swiss Franc weakens as Fed hawkish outlook lifts USD/CHF
Crypto prices
More
